Russell Clark Investment Management’s AbbVie ABBV Stock Holding History

Russell Clark Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$2.48M	Hold	23,000	–	–	2.47%	15
2021 Q2	$2.59M	Hold	23,000	–	–	1.95%	17
2021 Q1	$2.49M	Hold	23,000	–	–	2.02%	14
2020 Q4	$2.46M	Hold	23,000	–	–	2.32%	16
2020 Q3	$2.02M	Hold	23,000	–	–	2.28%	16
2020 Q2	$2.26M	Hold	23,000	–	–	3.48%	11
2020 Q1	$1.75M	Hold	23,000	–	–	2.63%	14
2019 Q4	$2.04M	Buy	23,000 +7,000	+44%	+$581K	1.58%	20
2019 Q3	$1.21M	Hold	16,000	–	–	0.96%	31
2019 Q2	$1.16M	Buy	16,000 +5,000	+45%	+$393K	0.74%	31
2019 Q1	$886K	Sell	11,000 -10,000	-48%	-$818K	0.3%	40
2018 Q4	$1.94M	Hold	21,000	–	–	0.7%	24
2018 Q3	$1.99M	Hold	21,000	–	–	0.47%	42
2018 Q2	$1.95M	Hold	21,000	–	–	0.38%	43
2018 Q1	$1.99M	Hold	21,000	–	–	0.4%	50
2017 Q4	$2.03M	Hold	21,000	–	–	0.43%	42
2017 Q3	$1.87M	Buy	21,000 +5,000	+31%	+$381K	0.41%	39
2017 Q2	$1.16M	Buy	+16,000	New	+$1.08M	0.32%	44

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Russell Clark Investment Management's ABBV Position: Q3 2021 in Review

Russell Clark Investment Management held its AbbVie (ABBV) position steady in Q3 2021 at 23,000 shares worth $2.48M. The position accounts for 2.47% of the portfolio, ranked #15.

Russell Clark Investment Management first reported a position in ABBV in Q2 2017 and has held it in 18 quarters since. The position peaked at $2.59M in Q2 2021. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

Russell Clark Investment Management held 23,000 shares of AbbVie worth $2.48M as of Q3 2021.
Russell Clark Investment Management left its AbbVie share count unchanged in Q3 2021.
AbbVie made up 2.47% of Russell Clark Investment Management's portfolio in Q3 2021, its #15 holding.
Russell Clark Investment Management first reported a position in AbbVie in Q2 2017 and has held it in 18 quarters since.
Russell Clark Investment Management's AbbVie position peaked at $2.59M in Q2 2021.
2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Russell Clark Investment Management's 13F filing for Q3 2021, filed 3 Nov 2021.